Related Experiment Video
Updated: Jun 17, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
Epidemiology of Invasive Meningococcal Disease in Colombia: A Retrospective Surveillance Database Analysis
Wilfrido Coronell-Rodriguez1, Diana C Caceres2, Otavio Cintra3
1Faculty of Medicine, University of Cartagena, Serena del Mar Hospital, Cartagena, Colombia.
Introduction:
Invasive meningococcal disease (IMD), caused by Neisseria meningitidis, is associated with high morbidity and mortality. The aim of the current study was to describe the historical and recent epidemiology of IMD in Colombia.
Methods:
This retrospective surveillance database analysis examined all available data on IMD in Colombia. Data were extracted from publicly available disease event reports and laboratory surveillance reports or obtained directly from hospitals in Cartagena.
Results:
During 2015-2021, the overall incidence of IMD was 0.04-0.18 per 100,000 based on laboratory surveillance reports. IMD incidence was highest among infants aged < 1 year (0.52-1.47 per 100,000), as was IMD mortality (0.00-0.65 per 100,000). Serogroup B was the dominant serogroup responsible for IMD in Colombia during 1988-2014, but, since 2015, serogroup C has been dominant in all age groups, followed by serogroups B and Y. During 2010-2021 combined, the majority of IMD cases were reported in Bogotá (31.9%) and Antioquia (21.7%). Of 42 IMD cases in the city of Cartagena, 54.8% occurred in people who lived in the poorest neighborhoods, and these patients had the highest IMD lethality (52.2%) and the shortest median hospitalization duration (3 days).
Conclusion:
The overall incidence of IMD in Colombia was low but was highest among infants aged < 1 year. IMD cases tended to be concentrated in the more densely populated areas and in poorer neighborhoods. As the majority of IMD cases in Colombia since 2015 have been serogroup C, followed by B or Y, vaccination to protect against these serogroups could potentially be beneficial and help to achieve the World Health Organization's and Pan American Health Organization's roadmaps to defeat meningitis by 2030.
Insights
Invasive meningococcal disease (IMD) incidence in Colombia is low but highest in infants. Serogroup C is now dominant, highlighting the need for targeted vaccination strategies.
Area of Science:
- Epidemiology
- Infectious Diseases
- Public Health
Background:
- Invasive meningococcal disease (IMD) presents significant morbidity and mortality risks.
- Understanding the epidemiology of IMD in Colombia is crucial for public health interventions.
Purpose of the Study:
- To analyze the historical and current epidemiological trends of IMD in Colombia.
- To identify high-risk populations and geographical distribution of IMD cases.
Main Methods:
- Retrospective analysis of surveillance data from 1988 to 2021.
- Data extraction from public reports and hospital records in Cartagena.
Main Results:
- IMD incidence ranged from 0.04-0.18 per 100,000 between 2015-2021, with highest rates in infants (<1 year).
- Serogroup C became dominant since 2015, followed by B and Y, shifting from the previous dominance of Serogroup B.
- Cases concentrated in Bogotá and Antioquia; Cartagena showed higher lethality in poorer neighborhoods.
Conclusions:
- IMD incidence is low overall but critical in infants.
- Serogroup C, B, and Y are key targets for vaccination efforts.
- Targeted vaccination strategies are recommended to align with global meningitis elimination goals.
Related Concept Videos
Investigation of Disease Outbreaks
Bacterial Meningitis
Viral Meningitis
Cryptococcal Meningitis
Toxoplasmosis
Brain Abscess l: Introduction

